(c) 2024 PillSync.com

methylphenidate hydrochloride tablet 54 mg extended release

1 INDICATIONS AND USAGE Methylphenidate HCl Extended-Release Tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14) ] . Methylphenidate HCl Extended-Release Tablets is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. ( 1 )

lannett company, inc.


4 years ago OVAL PINK 54 methylphenidate hydrochloride tablet 54 mg extended release

OVAL PINK 54

16 HOW SUPPLIED/STORAGE AND HANDLING Methylphenidate HCl Extended-Release Tablets, USP are available in 18 mg, 27 mg, 36 mg, and 54 mg dosage strengths. The 18 mg tablets are pink and imprinted with “18”, 27 mg tablets are yellow and imprinted with “27”, 36 mg tablets are pink and imprinted with “36”, and 54 mg tablets are pink and imprinted with “54”. All four dosage strengths are supplied in bottles containing 100 tablets. 18 mg 100 count bottle NDC 62175-310-37 27 mg 100 count bottle NDC 62175-311-37 36 mg 100 count bottle NDC 62175-312-37 54 mg 100 count bottle NDC 62175-313-37 Storage and Handling Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from humidity.


More pills like OVAL 54

Related Pills

Simvastatin 10 mg

Accord Healthcare, Inc.

Simvastatin 10 mg

Accord Healthcare, Inc.

Prednisone 20 MG Oral Tablet

Roxane Laboratories, Inc.

Spironolactone 50 MG Oral Tablet

McKesson Packaging Services Business Unit of

montelukast 10 mg

Aurobindo Pharma Limited

eszopiclone tablet

roxane laboratories, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site